Juric, D., de Bono, J. S., LoRusso, P. M., Nemunaitis, J., Heath, E. I., Kwak, E. L., . . . Tabernero, J. (2017). A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies. Clin Cancer Res.
Citação norma ChicagoJuric, Dejan, et al. "A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients With Advanced Solid Malignancies." Clin Cancer Res 2017.
MLA CitationJuric, Dejan, et al. "A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients With Advanced Solid Malignancies." Clin Cancer Res 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.